Literature DB >> 1569348

Distribution of polysaccharide side chains of lipopolysaccharide determine resistance of Escherichia coli to the bactericidal activity of serum.

R Porat1, R Mosseri, E Kaplan, M A Johns, S Shibolet.   

Abstract

The lipopolysaccharide (LPS) of serum-sensitive strains of Escherichia coli was compared with LPS derived from serum-resistant clones. Polysaccharide O-antigen side chains (PSSC) of LPS from serum-resistant clones contained 12%-40% more of the longer carbohydrate molecules (L-PSSC) than did LPS from serum-sensitive parent strains; in contrast, 12%-27% more of the shorter PSSC (S-PSSC) were found in LPS from serum-sensitive strains. The sensitivity or resistance to the bactericidal activity of human serum correlated with the distribution and the length of PSSC fractions of LPS. This was demonstrated in a liposome model in which LPS was incorporated into simulated bacterial membranes. The incubation of serum with liposomes incorporated with various ratios of S-PSSC-to-L-PSSC concentrations resulted in liposomal lysis at S-PSSC-to-L-PSSC ratios greater than 2:1. These findings demonstrate the importance of the length of carbohydrate side chains of LPS in determining sensitivity or resistance to the bactericidal activity of human serum.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1569348     DOI: 10.1093/infdis/165.5.953

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  12 in total

1.  Identification of the O antigen polymerase (rfc) gene in Escherichia coli O4 by insertional mutagenesis using a nonpolar chloramphenicol resistance cassette.

Authors:  S Lukomski; R A Hull; S I Hull
Journal:  J Bacteriol       Date:  1996-01       Impact factor: 3.490

Review 2.  Choice of bacteria in animal models of sepsis.

Authors:  A S Cross; S M Opal; J C Sadoff; P Gemski
Journal:  Infect Immun       Date:  1993-07       Impact factor: 3.441

3.  Assessment of complement-mediated killing of Moraxella (Branhamella) catarrhalis isolates by a simple method.

Authors:  C M Verduin; C Hol; E Van Dijke; J A Faber; M Jansze; J Verhoef; H Van Dijk
Journal:  Clin Diagn Lab Immunol       Date:  1995-05

4.  A single nucleotide exchange in the wzy gene is responsible for the semirough O6 lipopolysaccharide phenotype and serum sensitivity of Escherichia coli strain Nissle 1917.

Authors:  Lubomir Grozdanov; Ulrich Zähringer; Gabriele Blum-Oehler; Lore Brade; Anke Henne; Yuriy A Knirel; Ursula Schombel; Jürgen Schulze; Ulrich Sonnenborn; Gerhard Gottschalk; Jörg Hacker; Ernst T Rietschel; Ulrich Dobrindt
Journal:  J Bacteriol       Date:  2002-11       Impact factor: 3.490

5.  Cloning and expression of rfb genes from Vibrio anguillarum serotype O2 in Escherichia coli: evidence for cross-reactive epitopes.

Authors:  P A Amor; L M Mutharia
Journal:  Infect Immun       Date:  1995-09       Impact factor: 3.441

6.  Electrophoretic analysis of the lipopolysaccharides of Bacteroides spp.

Authors:  J P Maskell
Journal:  Antonie Van Leeuwenhoek       Date:  1994       Impact factor: 2.271

7.  Aeromonas salmonicida grown in vivo.

Authors:  R A Garduño; J C Thornton; W W Kay
Journal:  Infect Immun       Date:  1993-09       Impact factor: 3.441

8.  Rapid identification of common human pathogens by high-resolution proton magnetic resonance spectroscopy.

Authors:  E S Delpassand; M V Chari; C E Stager; J D Morrisett; J J Ford; M Romazi
Journal:  J Clin Microbiol       Date:  1995-05       Impact factor: 5.948

9.  Structural and serological specificities of Pasteurella haemolytica lipopolysaccharides.

Authors:  R P Lacroix; J R Duncan; R P Jenkins; R A Leitch; J A Perry; J C Richards
Journal:  Infect Immun       Date:  1993-01       Impact factor: 3.441

10.  Characterization of lipopolysaccharide-deficient mutants of Pseudomonas aeruginosa derived from serotypes O3, O5, and O6.

Authors:  T Dasgupta; T R de Kievit; H Masoud; E Altman; J C Richards; I Sadovskaya; D P Speert; J S Lam
Journal:  Infect Immun       Date:  1994-03       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.